What is the primary treatment for a patient diagnosed with tinea capitis favus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Capitis Favus

Griseofulvin is the treatment of choice for tinea capitis favus, given at 15-20 mg/kg/day for 6-8 weeks in children under 50 kg, or 1 g/day for 6-8 weeks in children over 50 kg and adults. 1, 2

Why Griseofulvin for Favus

  • Favus is caused by T. schoenleinii, a Trichophyton species that responds well to griseofulvin, making it the preferred first-line agent for this specific variant of tinea capitis 1, 3
  • Griseofulvin is FDA-approved for tinea capitis and has an excellent long-term safety record spanning decades of use 2, 4
  • The drug must be continued for the full 6-8 week course because favus is a chronic, inflammatory infection that can result in cicatricial (scarring) alopecia if inadequately treated 1

Dosing Algorithm

For children under 50 kg:

  • Give 15-20 mg/kg/day divided into doses (can be given as 125 mg four times daily, 250 mg twice daily, or as a single daily dose) for 6-8 weeks 1, 3, 2

For children over 50 kg and adults:

  • Give 1 g/day (can be divided as 250 mg four times daily or 500 mg twice daily) for 6-8 weeks 1, 3, 2

Higher doses may be needed for severe or extensive disease:

  • Start with 0.75-1.0 g/day in adults, then reduce gradually to 0.5 g after response is noted 2

Alternative Agents (Second-Line)

If griseofulvin fails or is not tolerated, consider:

  • Terbinafine: Weight-based dosing for 2-4 weeks (children <20 kg: 62.5 mg/day; 20-40 kg: 125 mg/day; >40 kg: 250 mg/day), though this is more effective for other Trichophyton species than for chronic favus 1, 3
  • Itraconazole: 5 mg/kg/day for 2-4 weeks, effective against Trichophyton species including T. schoenleinii 1, 3
  • Fluconazole: Can be used for refractory cases, though less cost-effective and not licensed for children under 10 years in the UK 1, 3

Critical Adjunctive Measures

Topical antifungal shampoos are mandatory as adjunctive therapy:

  • Use selenium sulfide or ketoconazole shampoo to reduce spore viability and prevent transmission 1, 4, 5
  • Apply twice weekly throughout the treatment course 1

Screen and treat all family members and close contacts:

  • More than 50% of family members may harbor infection, often asymptomatically 1
  • Failure to treat household contacts results in high recurrence rates 1

Cleanse all fomites:

  • Disinfect hairbrushes, combs, and towels with 2% sodium hypochlorite solution or bleach 1, 3
  • Viable spores can persist on these items and cause reinfection 1

Monitoring and Treatment Endpoints

The endpoint is mycological cure, not clinical improvement:

  • Repeat mycology sampling (scalp scraping, hair pluck, or brush) at the end of treatment 1, 3
  • Continue monthly sampling until microscopy and culture are negative 1, 3
  • Clinical improvement without mycological clearance will result in relapse 1, 2

Baseline and monitoring laboratory tests:

  • Obtain baseline liver function tests before starting griseofulvin, especially if pre-existing hepatic abnormalities exist 6
  • Monitoring during treatment is generally unnecessary for standard 6-8 week courses 5

Special Considerations for Favus

Favus fluoresces under Wood's lamp:

  • Use Wood's lamp examination to identify affected hairs for targeted sampling 1
  • This distinguishes favus from other tinea capitis variants 1

Watch for cicatricial alopecia:

  • Favus can cause permanent scarring alopecia if treatment is delayed or inadequate 1
  • Early diagnosis and complete mycological cure are essential to prevent this complication 1

Corticosteroids may be needed for severe inflammation:

  • If severe inflammatory response develops, topical or oral corticosteroids provide symptomatic relief 1, 5
  • Do not discontinue antifungal therapy when adding corticosteroids 1

Common Pitfalls to Avoid

  • Never use topical antifungals alone—they cannot penetrate the hair shaft and will fail to eradicate infection 1, 3
  • Do not stop treatment when clinical improvement occurs—continue until mycological cure is documented to prevent relapse 1, 2
  • Do not underdose griseofulvin—use 15-20 mg/kg/day, not lower doses, as treatment failures are increasing with suboptimal dosing 3
  • Do not confuse favus with bacterial abscess—the yellow crusted scutula are fungal, not bacterial, though secondary bacterial infection can occur 1

School Attendance

Children on appropriate systemic and topical therapy can attend school:

  • Exclusion from school is impractical and unnecessary once treatment is initiated 1, 3
  • Ensure compliance with both oral antifungal and adjunctive topical therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Tinea Capitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinea capitis: a treatment update.

Pediatric annals, 2005

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.